Aktiv Pharma Group to Participate in the FDA Emerging Technology Progr
Broomfield, CO (PRWEB) September 26, 2022
Aktiv Pharma Group (Aktiv) announced today the acceptance of its novel glass-free, film-based flexible primary drug container (PDC) technology for steril
Previous post
insert_link
share
close
The Tech That Will Push VR to the Limits of the Human Eye
To meet its potential, VR needs better displays with far more pixels per inch. Luckily, experts say new materials and designs are on the way.
Similar posts
Why this new plant is capturing carbon dioxide just to let it back out again
After years of drama, Global Thermostat has a new game plan.
Post comments (0)